The joint clinical research office builds on the work the organizations have done over the last seven months to collaboratively launch about 35 COVID-19 clinical trials, several of which are part of larger national clinical trials. Including the COVID-19 trials, Tampa General and USF Health are working together on about 350 research studies.
“We already have established and invested in a strong foundation for clinical research,” Tampa General President and CEO John Couris said in a news release. “Combining the efforts of TGH and USF Health is the next step to elevate the world-class research we do to push forward to the edge of scientific discovery.”
More articles on healthcare industry transactions:
Steward acquires 3 hospitals in Colombia
Washington hospital unwinds from Virginia Mason
Merger would create 4-hospital system in Southern Illinois
